COVID-19

Views & Analysis

ABPI’s Sheuli Porkess on how COVID-19 could improve clinical...

COVID-19 has shifted the global gaze onto the topic of medical research – and is starting to transform the way we see and do clinical trials.

News

Oxford Biomedica signs COVID-19 vaccine supply deal with AZ

Gene and cell therapy specialist Oxford Biomedica has signed a one-year agreement with AstraZeneca to manufacture the potential COVID-19 vaccine in development in partnership with Oxford Un

News

GSK to produce a billion doses of COVID-19 vaccine booster b...

GlaxoSmithKline is to scale up production of its COVID-19 vaccine booster to a billion doses by 2021 to support development of several potential jabs.

News

PureTech to develop drug to treat lung scarring in COVID-19 ...

US biotech PureTech is to develop its most advanced pipeline drug LYT-100 as a potential treatment for inflammation and lung scarring in patients who have serious cases of COVID-19 or who h

News

UK okays early access to Gilead's remdesivir in seriously il...

The UK’s drugs regulator has said that there is enough evidence to support the use of Gilead’s COVID-19 drug remdesivir under its Early Access to Medicines Scheme (EAMS).

Views & Analysis